MoneyWorks4Me

Natco Pharma submits copy of press release

25 Aug 2016 Evaluate

Natco Pharma has submitted a copy of Press Release dated August 25, 2016 titled ‘NATCOs marketing partner Mylan Invalidates Two of Tevas Copaxone 40 mg/mL Patents Via US Patent and Trademark Offices Inter Partes Review Proceeding’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..